Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Mathews"


25 mentions found


Handout via REUTERS/File photo Acquire Licensing RightsSummaryCompanies Ozempic shortages expected throughout 2024Victoza shortages expected until at least Q2 2024Diabetes drug Ozempic used 'off label' to treat obesityNov 21 (Reuters) - Novo Nordisk (NOVOb.CO) will ration starter kits of Ozempic in Europe and reduce supplies of another diabetes drug, Victoza, to prioritise producing Ozempic, which has seen a surge in demand from people using it to lose weight. Ozempic contains semaglutide, an ingredient in Novo's hugely popular anti-obesity drug Wegovy. Intermittent Ozempic shortages are expected throughout 2024, while Victoza shortages are expected at least until the second quarter of 2024, according to the statement on the EMA's website. "No new patients should be started on Victoza until at least Q2 2024 when supply is expected to normalise," Novo urged doctors in the document. It also told doctors to consider other injectable GLP-1 drugs or "other suitable alternatives" where Ozempic or Victoza are not available for patients.
Persons: Ozempic, hasn't, Novo, Eli Lilly's, tirzepatide, Ludwig Burger, Eva Mathews, Emelia Sithole, Mark Potter Organizations: Handout, REUTERS, Diabetes, Novo Nordisk, European Medicines Agency, EU, Thomson Locations: Novo, London, Britain, Europe, Danish, United States, France, Austria, Belgium, Germany, Wegovy, Norway, Denmark, EU
Jana Mathews , a professor of Medieval literature at Rollins College, checks the bathrooms to coax out students hiding from the big event in her Job Market Boot Camp class, a mixer with alumni to practice professional networking. For many of her students, the face-to-face conversations with strangers are more nerve-racking than decoding Chaucer. Sydney Parmet had trouble sleeping the night before and considered skipping it. “I kept overthinking what I was going to say and second-guessed whether I should say anything,” said Parmet, who graduated in May from the Winter Park, Fla., campus.
Persons: Jana Mathews, Sydney Parmet, , , Parmet Organizations: Rollins College Locations: Fla
LSEG names Publicis finance chief Michel-Alain Proch as CFO
  + stars: | 2023-11-20 | by ( ) www.reuters.com   time to read: 1 min
Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/File Photo Acquire Licensing RightsNov 20 (Reuters) - The London Stock Exchange Group (LSEG.L) on Monday named Michel-Alain Proch as its new finance chief, starting March 1, 2024. Proch, who currently serves as group CFO of advertising group Publicis <PUBP.PA>, takes on the role from Anna Manz, who stepped down in May. Last week, LSEG, which owns London's 300-year old stock exchange, raised its mid-term growth guidance to "mid-to-high single" digits and said it would return a billion pounds to shareholders in 2024 as it looks beyond the integration of data and analytics company Refinitiv. Reporting by Eva Mathews in Bengaluru; Editing by Sonia CheemaOur Standards: The Thomson Reuters Trust Principles.
Persons: Toby Melville, Michel, Alain Proch, Proch, Anna Manz, Eva Mathews, Sonia Cheema Organizations: London Stock Exchange, REUTERS, Thomson Locations: Canary Wharf, London, Britain, Bengaluru
It was a remarkable journey for Australia, who began their campaign with back-to-back defeats yet still finished with the 50-overs World Cup in their arms for the sixth time. Shakib had already caused controversy over his appeal that led to Sri Lanka's Angelo Mathews becoming the first player in international cricket to be 'timed-out'. Cummins, for one, had no doubts about the stature of the original World Cup. "I think it's the pinnacle of international cricket," said Cummins, who was part of Australia's victorious 2015 squad. "The whole cricket world stops with this World Cup."
Persons: Narendra Modi, Adnan Abidi, Cummins, Travis, Jos Buttler, Jonathan Trott, Australia's Glenn Maxwell, Babar Azam, Shakib Al Hasan's, Shakib, Sri Lanka's Angelo Mathews, Mathews, Buttler, Anurag Dahiya, Mark Twain's, Amlan Chakraborty, Peter Rutherford Organizations: Cricket, ICC Cricket, Narendra, Australia, ICC Cricket World, REUTERS, Rights, India, The, West Indies, Sri, WORLD, International Cricket Council, ICC, T20, Pakistan, Thomson Locations: India, Australia, Ahmedabad, Rights AHMEDABAD, England, Pakistan, Sri Lanka, Bangladesh, Australia's, Dharamsala, New Delhi
The Glazer family announced last November that they were exploring "strategic alternatives" for the club, including a possible sale and were open to fresh investment. Manchester United's U.S.-listed shares rose 9.5% to $20.10 in early trading on Friday. Manchester United generates more revenue and has a larger fan base than its London rival. The Glazer family has faced intense criticism from fans over its handling of this key part of the club's operations. The six descendants of American businessman Malcolm Glazer, who died in 2014, currently control 96% of Manchester United's voting stock.
Persons: Glazer, Jim Ratcliffe, Ratcliffe, Sir Alex Ferguson, Richard Arnold, Roman Abramovich, Todd Boehly, Phil Noble, Malcolm Glazer, Ineos, Eva Mathews, Matt Scuffham, Arun Koyyur, Susan Fenton Organizations: Manchester, soccer, Sky News, Old, Manchester United, Premier League soccer, Chelsea, U.S, Clearlake, REUTERS, Reuters, Tampa Bay Buccaneers, Forbes, Ligue, Nice, Swiss Super League, FC Lausanne, Racing Club Abidjan, Ivory Coast Ligue, Grenadiers, Thomson Locations: Old Trafford, Manchester United's U.S, London, Manchester, Britain, Ineos, British, Bengaluru
The offer represents a premium of 79.1% to the stock's Thursday closing price of $18.43, which gave the Old Trafford club a market capitalization of about $3 billion. Ratcliffe, also the chair of petrochemicals firm Ineos, would pay more than $1.5 billion for a 25% stake in United if his bid for the soccer club is accepted, Reuters reported in October. The Glazer family, which made its fortune in real estate, retail and healthcare and owns the NFL's Tampa Bay Buccaneers, bought the team for 790 million pounds in 2005. The six descendants of American businessman Malcolm Glazer, who died in 2014, together control 96% of Manchester United's voting stock. The deal was yet to be finalised and remained the subject of ongoing negotiations, Sky News reported on Friday.
Persons: Jim Ratcliffe, Phil Noble, Glazer, Ratcliffe, Malcolm Glazer, Richard Arnold, Patrick Stewart, Eva Mathews, Arun Koyyur Organizations: REUTERS, Manchester, soccer, Sky News, Old, U.S, Reuters, Tampa Bay Buccaneers, Premier League, Thomson Locations: Old Trafford, Manchester, Britain, United, Bengaluru
UK insurer Aviva posts 13% rise in nine-month premiums
  + stars: | 2023-11-16 | by ( ) www.reuters.com   time to read: +2 min
A man walks past an AVIVA logo outside the company's head office in the city of London March 5, 2009. REUTERS/Stephen Hird (BRITAIN)/File Photo Acquire Licensing RightsLONDON, Nov 16 (Reuters) - British insurer Aviva (AV.L) on Thursday posted a 13% rise in its general insurance gross written premiums for the first nine months of the year, saying it would continue to return surplus capital to shareholders. Insurers have dealt with issues such as rising inflation and the higher cost of claims by increasing premiums. The life and general insurer, whose main markets are Britain, Canada and Ireland, reported premiums of 8 billion pounds ($9.91 billion), up from 7.2 billion a year earlier. "We see significant opportunities to generate further higher return, capital-light growth in the future as we prioritise these segments."
Persons: Stephen Hird, Amanda Blanc, Blanc, Eva Mathews, Carolyn Cohn, Huw Jones, Sherry Jacob, Phillips, Jason Neely Organizations: AVIVA, REUTERS, Aviva, RSA, Reuters, Thomson Locations: London, BRITAIN, British, Britain, Canada, Ireland, Bengaluru
REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsNov 14 (Reuters) - Imperial Brands (IMB.L) on Tuesday forecast revenue and profit growth next year led by the second half helped by pricing actions and investments in tobacco alternatives. The maker of Winston cigarettes, Backwoods cigars and Golden Virginia rolling tobacco reported an adjusted operating profit of 3.89 billion pounds ($4.78 billion) for the year ended Sept. 30, up from 3.69 billion. Imperial said next year it anticipates low-single-digit revenue growth, while it expects adjusted operating profit close to the middle of its mid-single digit range. This means adjusted operating profit will likely grow by low single digits in the first half, it continued. Imperial raised its annual dividend by 4%, and said its ongoing multi-year share buyback would increase 10% in 2024.
Persons: Dado Ruvic, Winston, Stefan Bomhard, Imperial, Eva Mathews, Emma Rumney, Subhranshu Sahu, Jason Neely Organizations: Imperial Brands, REUTERS, Thomson Locations: Virginia, Bengaluru, London
"Macroeconomic pressures in the region are resulting in lower consumption and consumer downtrading," the world's biggest spirits maker said. Last month, Mexico's Becle (CUERVO.MX), the world's largest tequila producer, said economic challenges in Europe and Latin America were slowing customer spending on liquor, which battered its profits. "Over time, as inflation moderates and productivity from our supply agility program flow through, we expect operating profit to grow ahead of organic net sales growth," Diageo said. Diageo narrowly beat earnings estimates for the year ended June 30, as sales of its more expensive liquor brands offset lower volumes. Reporting by Eva Mathews in Bengaluru; Editing by Rashmi Aich, Emelia Sithole-Matarise and Alexander SmithOur Standards: The Thomson Reuters Trust Principles.
Persons: Clodagh, Johnnie Walker, Julio, Sophie Lund, Yates, Hargreaves Lansdown, Mexico's, Eva Mathews, Rashmi Aich, Emelia, Alexander Smith Organizations: REUTERS, Caribbean ., Diageo, Thomson Locations: Dublin, Ireland, North America, Africa, Latin America, Europe, America, Bengaluru
Pints of Guinness are seen in a pub, in Dublin, Ireland March 20, 2023. REUTERS/Clodagh Kilcoyne/File Photo Acquire Licensing RightsNov 10 (Reuters) - Johnnie Walker whisky maker Diageo (DGE.L) on Friday said it expected organic operating profit growth to decline in the first half of its current financial year due to "materially weaker" performance in Latin America and Caribbean. "Macroeconomic pressures in the region are resulting in lower consumption and consumer downtrading," the world's biggest spirits company said in a statement. Latin America and Caribbean makes up nearly 11% of the company's net sales, according to Diageo. Sales in the region are now expected to decline by more than 20%, year-on-year, in the first half of fiscal 2024, the company added.
Persons: Clodagh, Johnnie Walker, Eva Mathews, Rashmi Organizations: REUTERS, Diageo, Thomson Locations: Dublin, Ireland, America, Caribbean, Bengaluru
It also expects total revenue to increase by a mid single-digit percentage, compared with low-to-mid single-digit growth previously. For the third consecutive quarter, strong sales of AstraZeneca's blockbuster cancer treatments and healthy demand for its drugs in emerging markets offset the loss of sales of its COVID-19 vaccine and therapy. The results add to a string of strong quarters for Britain's biggest company by market capitalisation - worth 159 billion pounds ($195 billion) - bolstered by a strong pipeline of drugs. It said that in the first nine months of 2023, nine medicines delivered more than $1 billion in revenue. Excluding sales of its COVID-19 products, third-quarter sales rose 12% to $2.96 billion in emerging markets on a constant currency basis.
Persons: Phil Noble, China's, Maggie Fick, Eva Mathews, Nivedita Bhattacharjee, Mark Potter Organizations: AstraZeneca, REUTERS, Britain's, Thomson Locations: Macclesfield, England, China, London, Swedish, Bengaluru
Bangladesh captain Shakib ruled out of final World Cup game
  + stars: | 2023-11-07 | by ( ) www.reuters.com   time to read: +1 min
Cricket - ICC Cricket World Cup 2023 - Bangladesh v Sri Lanka - Arun Jaitley Stadium, New Delhi, India - November 6, 2023 Bangladesh's Shakib Al Hasan in action as he scores four runs REUTERS/Anushree Fadnavis Acquire Licensing RightsNov 7 (Reuters) - Bangladesh captain Shakib Al Hasan will miss his team's final World Cup match after fracturing his finger during their win over Sri Lanka, the Bangladesh Cricket Board said on Tuesday, and will be replaced by Anamul Haque. Shakib scored 82 in Delhi, helping Bangladesh chase down 280, and took two wickets in a man-of-the-match performance. "He underwent an emergency X-ray in Delhi after the game which confirmed the fracture on the left PIP joint. Shakib, 36, also made the appeal that led to the controversial time-out dismissal of Sri Lanka batter Angelo Mathews who called him a "cheat" on social media. The Event Technical Committee of the ICC Cricket World Cup has approved Anamul Haque Bijoy, who has played 45 ODIs, as Shakib's replacement.
Persons: Arun Jaitley, Shakib Al Hasan, Anushree, Anamul Haque, Shakib, Khan, Sri, Angelo Mathews, Anamul Haque Bijoy, Chiranjit, Ed Osmond Organizations: Cricket, ICC Cricket, Arun, Sri, Bangladesh Cricket Board, Australia, Thomson Locations: Bangladesh, Sri Lanka, New Delhi, India, Delhi, Bengaluru
REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsCompanies Haleon Plc FollowGSK plc FollowNov 2 (Reuters) - Haleon (HLN.L) missed market estimates for third-quarter revenue on Thursday, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, digestive health and vitamin supplements in North America. For the three months ended Sept. 30, Haleon reported a 5% organic increase in revenue to 2.79 billion pounds ($3.40 billion), but it came slightly below analysts' expectations of 2.83 billion pounds, according to a company-compiled consensus. The company said overall volumes for the quarter declined by 1.6%, while North America revenues fell 7.5% on a reported basis. Haleon, which was carved out of British drugmaker GSK (GSK.L) last year, has been raising prices to offset high costs. ($1 = 0.8215 pounds)Reporting by Eva Mathews in Bengaluru; Editing by Rashmi Aich and Gerry DoyleOur Standards: The Thomson Reuters Trust Principles.
Persons: Brendan McDermid, Haleon, Eva Mathews, Rashmi Aich, Gerry Doyle Organizations: New York Stock Exchange, REUTERS, GSK, Consumer, Thomson Locations: New York City, U.S, North America, British, Bengaluru
GSK raises annual forecasts powered by strong Arexvy launch
  + stars: | 2023-11-01 | by ( ) www.reuters.com   time to read: +2 min
Analysts expect the British drugmaker's RSV vaccine Arexvy to power future growth, amid worries about the strength of its pipeline of drugs in development and costly U.S. litigation over discontinued heartburn drug Zantac. Arexvy, launched in the United States recently, is expected to garner full-year sales of between 900 million pounds to 1 billion pounds ($1.22 billion), GSK said. For the third quarter, the shot recorded sales of 709 million pounds, trouncing analysts' expectations of 358 million pounds, according to a company-compiled consensus. Meanwhile, sales are seen to rise by 12% to 13% in 2023 compared with earlier expectations of 8% to 10%. For the reported quarter, sales of Shingrix, the company's top-selling drug to treat shingles, generated 825 million pounds, below market estimates of 868 million pounds.
Persons: Dado Ruvic, Eva Mathews, Subhranshu Sahu, Tomasz Janowski Organizations: GSK, GlaxoSmithKline, REUTERS, Thomson Locations: United States, Bengaluru
Arexvy, launched in the United States recently, recorded third quarter sales of 709 million pounds ($862 million), trouncing analysts' expectations of 358 million pounds, according to a company-compiled consensus. GSK accounts for close to two-thirds of RSV shots given in the United States since early September, according to IQVIA data. Full-year sales are seen between 900 million pounds and 1 billion pounds for the shot, GSK said. The company faces about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware and scheduled for trial starting January 2024. For the third quarter, Shingrix, the company's top-selling drug for shingles, generated 825 million pounds in sales.
Persons: Dado Ruvic, Abrysvo, Dani Saurymper, Emma Walmsley, Eva Mathews, Maggie Fick, Tomasz Janowski, Mark Potter Organizations: GSK, GlaxoSmithKline, REUTERS, stg, CVS, Pfizer, Pacific Asset Management, GSK's, Thomson Locations: London, United States, U.S, Europe, Japan, Delaware, Bengaluru
BENGALURU, Oct 26 (Reuters) - Sri Lanka restricted England to a below-par 156 all out in 33.2 overs in a must-win clash between the World Cup's stragglers on Thursday, with only Ben Stokes offering some resistance in a dismal batting display by the defending champions. Stokes (43) took the attack to Sri Lanka on a dry wicket at the M Chinnaswamy Stadium after England's middle-order collapsed in the face of some incisive bowling, but he holed out to Dushan Hemantha in the deep off Lahiru Kumara (3-35) in the 31st over. Sri Lanka earlier put the brakes on England's scoring as returning veteran Angelo Mathews (2-14) removed opener Dawid Malan (28) and helped run out Joe Root, before Kumara struck twice to leave the holders in trouble at 85-5. Sri Lanka, who came into the contest with the same record as England with three defeats in four matches, ran through the tail to lay the platform for a big upset. Reporting by Shrivathsa Sridhar in Bengaluru; editing by John Stonestreet and Christian RadnedgeOur Standards: The Thomson Reuters Trust Principles.
Persons: Ben Stokes, Stokes, Kumara, Jos Buttler, Jonny Bairstow, Kasun, Angelo Mathews, Dawid Malan, Joe Root, Mathews, Matheesha, snared Moeen Ali, Chris Woakes, Sadeera Samarawickrama, Shrivathsa Sridhar, John Stonestreet Organizations: England, Thomson Locations: BENGALURU, Sri Lanka, England, Bengaluru
BENGALURU, Oct 26 (Reuters) - Sri Lanka spinner Maheesh Theekshana praised all-rounder Angelo Mathews for adding discipline to their bowling attack after the veteran claimed two wickets in miserly spells during Thursday's thumping victory over defending world champions England. Theekshana credited Mathews and player of the match Lahiru Kumara (3-35) for getting them back on track after England made a good start with 59 runs in the first 10 powerplay overs on a dry wicket in Bengaluru. "In the initial four or five overs, we conceded a few runs due to our inability to find the right length," Theekshana told reporters. So, we had a chance to take wickets, that's what we planned here." "I think they underestimated our team, because we also lost three games and we only won against the Netherlands," he said.
Persons: Maheesh Theekshana, Angelo Mathews, Mathews, Matheesha Pathirana, Theekshana, Kumara, Angelo, Lahiru, Shrivathsa Sridhar, Ken Ferris Organizations: England, Pakistan, Thomson Locations: BENGALURU, Sri Lanka, England, Bengaluru, Netherlands
Figurines are seen in front of displayed Adobe logo in this illustration taken June 13, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 25 (Reuters) - Britain's competition regulator, on Wednesday, extended by eight weeks the deadline to complete its in-depth probe into Photoshop owner Adobe Inc's (ADBE.O) $20 billion buyout of cloud-based designer platform Figma, to February 2024. The CMA now has until Feb. 25 to conclude its investigation, compared to the earlier deadline of Dec. 27. In September 2022, Adobe announced a cash-and-stock deal for Figma, the biggest buyout of a privately owned software startup. Reporting by Eva Mathews in Bengaluru; Editing by Sherry Jacob-Phillips and Savio D'SouzaOur Standards: The Thomson Reuters Trust Principles.
Persons: Dado Ruvic, Eva Mathews, Sherry Jacob, Phillips, Savio D'Souza Organizations: REUTERS, Adobe, Markets Authority, CMA, Figma, Zoom Video Communications, Airbnb Inc, Thomson Locations: Bengaluru
Average annual contributions to premiums For single coverage For family coverage $23,968 total $25,000 $25,000 Worker contribution Employer contribution 20,000 20,000 15,000 15,000 $6,575 worker share $8,435 total 10,000 10,000 5,000 5,000 $1,401 worker share 0 0 2000 '05 '10 '15 '20 2000 '10 '20 Average annual contributions to premiums For single coverage For family coverage $23,968 total $25,000 $25,000 Worker contribution Employer contribution 20,000 20,000 15,000 15,000 $6,575 worker share $8,435 total 10,000 10,000 5,000 5,000 $1,401 worker share 0 0 2000 '05 '10 '15 '20 2000 '10 '20 Average annual contributions to premiums Worker contribution Employer contribution For single coverage $8,435 total $10,000 5,000 $1,401 worker share 0 2000 '05 '10 '15 '20 For family coverage $23,968 total $25,000 20,000 15,000 $6,575 worker share 10,000 5,000 0 2000 '10 '20 Average annual contributions to premiums Worker contribution Employer contribution For single coverage $8,435 total $10,000 5,000 $1,401 worker share 0 2000 '05 '10 '15 '20 For family coverage $23,968 total $25,000 20,000 15,000 $6,575 worker share 10,000 5,000 0 2000 '10 '20Inflation came for your healthcare this year. Next year is looking to be just as bad. The cost of employer health insurance rose this year at the fastest clip since 2011, according to an annual survey from KFF, a healthcare research nonprofit. The 7% jump in the cost of a family plan brought the average tab to nearly $24,000—more than the price for some small cars.
Locations: KFF
Shares in the British company, originally a brewer, were up 3.5% to 3,437 pence by 0737 GMT to lead London's blue-chip (.FTSE) index. Leisure and business demand are showing signs of staying, Paul said, adding forward-booked revenue was ahead of last year. Whitbread, which owns restaurant chains such as Bar+Block Steakhouse and Brewers Fayre has also seen signs of food inflation easing. The company announced a further 300 million pound share buyback on Wednesday and proposed an interim dividend per share of 34.1 pence, up 40% on last year. ($1 = 0.8193 pounds)Reporting by Eva Mathews in Bengaluru; editing by Subhranshu Sahu and Jason NeelyOur Standards: The Thomson Reuters Trust Principles.
Persons: Lee Smith, WTB.L, Dominic Paul, Paul, Whitbread, Hargreaves, Derren Nathan, Brewers Fayre, Eva Mathews, Subhranshu Sahu, Jason Neely Organizations: Premier Inn Hotel, Brewers, REUTERS, H1, Whitbread, Inn, Thomson Locations: Durham, County Durham, Britain, British, Germany, Bengaluru
A sign of Wagamama restaurant is seen in London, Britain, October 5, 2020. Under the terms of the deal announced on Thursday, The Restaurant Group's (TRG) shareholders will get 65 pence in cash for each share held, a premium of about 34% to the stock's last closing price. Shares in the small cap constituent (.FTSC) jumped 37.1% to 66.5 pence, its highest percentage gain since April 2020. There has also been pressure from shareholders and activist investors Irenic Capital and Oasis Management in recent months to change management and improve profitability. Another analyst at Shore Capital said the offer price was "too low" given the company's efforts to improve margins and reduce leverage.
Persons: Hannah McKay, Ken Hanna, Benny's, Eva Mathews, Subhranshu Sahu, Elaine Hardcastle, Miral Organizations: REUTERS, Apollo, Irenic Capital, Oasis Management, Cafe, Shore Capital, Thomson Locations: London, Britain, TRG, Cafe Rouge, Bengaluru
The trial for the Cantlay/Harper case, which was set to begin on Nov. 13, will now be dismissed, GSK said, adding it had also settled three remaining breast cancer cases in California related to the same drug. The latest settlements in California were related to cases due to go to trial in November, with a further set scheduled to begin in Delaware courts in January, GSK said. The company still faces about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware. GSK did not admit any liability and said it would vigorously defend itself in any other Zantac cases. In June, GSK agreed to settle a similar lawsuit in California.
Persons: Harper, Brendan McDermid, Morgan, Jeffries, Zantac, Boehringer Ingelheim, Eva Mathews, Maggie Fick, Nivedita Bhattacharjee, Bernadette Baum, Louise Heavens, Emelia Organizations: pare, Citi, GSK, Reuters, REUTERS, Barclays, Pfizer, Sanofi, FDA, Thomson Locations: California, British, Delaware, United States, Arexvy, California . California, Bengaluru, London
REUTERS/Brendan McDermid/Illustration/File Photo Acquire Licensing RightsOct 11 (Reuters) - GSK (GSK.L) on Wednesday said it would confidentially settle another lawsuit in California alleging its discontinued heartburn drug Zantac caused cancer, as the British drugmaker sought to end costly litigation. The latest settlements in California related to cases due to go to trial in November, with a further set scheduled to begin in Delaware courts in January, GSK said. The company still faces about 79,000 cases related to Zantac in the United States, with 73,000 of them in Delaware. Late in June, the company agreed to settle a similar lawsuit with California resident James Goetz who alleged he developed bladder cancer after taking Zantac. The settlement could be read that GSK sees a risk that these Zantac cases are strong enough that the company might lose at trial, J.P Morgan added.
Persons: Brendan McDermid, Morgan, Harper, Zantac, Boehringer Ingelheim, James Goetz, J.P Morgan, Eva Mathews, Maggie Fick, Nivedita Bhattacharjee, Bernadette Baum Organizations: REUTERS, GSK, Citi, J.P, Pfizer, Sanofi, FDA, Thomson Locations: California, British, Delaware, United States, Bengaluru, London
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharmacy-giant-walgreens-names-new-ceo-22b665d8
Persons: Dow Jones, 22b665d8 Organizations: walgreens
REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsLONDON/SHANGHAI Oct 9 (Reuters) - China's largest vaccines company Zhifei (300122.SZ) will pay British drugmaker GSK (GSK.L) 2.5 billion pounds ($3.05 billion pound) for the exclusive rights to distribute GSK's shingles vaccine in the world's No.2 pharmaceuticals market. The deal with Zhifei is part of its efforts to reach more 4 billion pounds ($4.88 billion) in sales by 2026, GSK said. Zhifei will purchase volumes of Shingrix with a value to GSK worth 2.5 billion pounds over an initial three-year period, GSK said. Zhifei shares were up as much as 20% to 58.40 yuan ($8.00) following the filing, their highest point since March 27. Shingrix is currently GSK's biggest product and strongest growth driver, taking in 1.71 billion pounds in first-half sales, up 20% from a year prior.
Persons: Dado Ruvic, Zhifei, Shingrix, Maggie Fick, Andrew Silver, Eva Mathews, Savio D'Souza, Louise Heavens Organizations: GSK, GlaxoSmithKline, REUTERS, British, AstraZeneca, Zhifei, Barclays, Reuters, Thomson Locations: SHANGHAI, China, United States, London, Shanghai, Bengaluru
Total: 25